Abcombi Biosciences is a pre-clinical vaccine and therapeutic development company dedicated to delivering “smarter” vaccine and anti-infective solutions. Our corporate headquarters are in Buffalo, New York. We have developed key technologies and analytical strategies to facilitate our unique protection strategies:
-Our novel biofilm model that mimics the natural progression of disease for colon
izing bacteria such
Streptococcus pneumoniae and Staphylococcus aureus.
-Application of bioinformatics in conjunction with our biofilm model to identify antigens associated with
specific stages of disease progression.
-A novel formulation strategy that removes the need for complex chemistry to produce polysaccharide
conjugate vaccines.
-Broad RNA-based therapy for treating influenza infections. At Abcombi, we harness these potent tools to provide universally protective interventions for complex diseases such as pneumonia and influenza.
